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Abstract 
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Nitric oxide (NO) is synthesized from a unique precursor, arginine, by nitric oxide synthase 
(NOS). In brain cells, arginine is supplied by protein breakdown or extracted from the blood 
through cationic amino acid transporters (CATs). Arginine can also be recycled from the 
citrulline produced by NOS activity, through argininosuccinate synthetase (AS) and 
argininosuccinate lyase (AL) activities, and metabolized by arginase. NOS, AS and AL 
constitute the so-called citrulline-NO cycle. In order to better understand arginine transport, 
recycling and degradation, we studied the regional distribution of cells expressing CAT1, 
CAT3, AS, AL, neuronal NOS (nNOS) and arginase II (AII) in the adult rat brain by non-
radioisotopic in situ hybridization. CAT1, AL and AII presented an ubiquitous neuronal and 
glial expression, whereas CAT3 and AS were confined to neurons. nNOS was restricted to 
scattered neurons and a few brain nuclei and layers. We demonstrate by this study that cells 
expressing nNOS all appear to express the entire citrulline-NO cycle, whereas numerous cells 
expressing AL do not express AS. The differential expression of these genes within the same 
anatomical structure could indicate that intercellular exchanges of citrulline-NO cycle 
metabolites are relevant. Thus vicinal interactions should be taken into account to study their 
regulatory mechanisms. 
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1. Introduction 
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Nitric oxide (NO) is an important cell-cell signalling molecule in the central nervous system 
(CNS) [14]. It is synthesized from a unique precursor, L-arginine, through nitric oxide 
synthase (NOS) activity [30]. The NO production capacity is dependent on the intracellular 
arginine concentration. Arginine is also utilized for the synthesis of proteins and creatine, and 
is metabolized by arginase to ornithine and urea (Figure 1). There is no de novo synthesis of 
arginine in CNS, since the mitochondrial urea cycle enzymes carbamoylphosphate synthetase 
and ornithine transcarbamylase are not expressed. For their needs in arginine, brain cells 
depend on protein breakdown and on specific transporters to import arginine from the blood 
or transfer it from cell to cell [26]. Arginine can also by recycled from the citrulline generated 
by the NOS activity, in a reaction catalized by the cytosolic argininosuccinate synthetase (AS) 
and argininosuccinate lyase (AL). This constitutes the so-called citrulline-NO cycle or 
arginine-citrulline cycle (Figure 1, reviewed in [42]). In the brain, arginine levels and NO 
production appear to be at a pivotal place in the pathophysiology of hyperammonemic 
disorders [32,33], where, in astrocytes of aggregating neural cell cultures, the expression of 
AS and AL genes is induced [7]. 
 
L-arginine is transported through cell membrane by carriers designated as system y+ [26]. In 
CNS and neural cell cultures, the system y+ was identified at the blood brain barrier [40], in 
primary cultured astrocytes [35], in cultured neurons from neocortex and cerebellum [46] as 
well as in synaptosomes extracted from cortex and cerebellum [1]. System y+ carriers are a 
family of cationic amino acid transporters called CATs [26]. Up to now, four different CAT 
proteins have been identified. CAT1 is considered to be ubiquitously expressed except in liver 
[22], CAT2(B) is expressed in different tissues including brain but absent in liver [25], 
CAT2A, an alternatively spliced variant of CAT2(B), is restricted to liver [11], and CAT3 
was recently isolated from the rodent brain [17,18]. CAT 1, 2(B) and 3 present a high affinity 
for arginine (apparent Km around 100 µM), whereas CAT2A has a much lower affinity 
profile (apparent Km of 2 to 5 mM). CAT1 and CAT2(B) have been described in whole brain 
homogenates [22,25]. However, data on the precise identification and localization of CAT 
transporters responsible for the arginine trafficking between the different cell types of the 
brain are still lacking, except for the neurospecific CAT3 which seems to be expressed in 
restricted areas of the brain [17,18]. 
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In the brain, the recycling of arginine from citrulline has been proposed to occur in neurons 
[10]. AS and AL activities have been described since a long time in CNS [34]. In the rat 
brain, AS has been localized by immunohistochemistry in specific subsets of neurons, 
whereas AL was found in a specific glial subtype of cerebellum as well as neurons of the 
whole brain [4,27,28]. Thus, AS and AL appear to be expressed predominantly in neurons in 
the normal brain. However, AS and AL genes were found induced by cyclic AMP and 
glucocorticoids in primary astrocyte cultures [21] and by hyperammonemia in aggregating 
brain cell culture astrocytes [7]. The AS protein was recently found increased in cultured 
primary astrocytes after treatment with lipopolysaccharide (LPS) and interferon-γ (IFNγ) [36]. 
 
Three NOS isoforms have been described, namely neuronal NOS (nNOS), endothelial NOS 
(eNOS) and inducible NOS (iNOS) (reviewed in [23]). nNOS is constitutively expressed in 
CNS, and recent studies described the precise distribution of nNOS mRNA and protein in 
discrete populations of neurons of the adult rat brain [8,19]. eNOS plays also a role in CNS, 
as mice doubly disrupted for nNOS and eNOS present a reduction of long term potentiation in 
the CA1 region, whereas single nNOS disrupted mice do not [37]. eNOS seems restricted to 
the brain vasculature [38]. There is increasing evidence of the involvement of iNOS in aging 
CNS and neurodegenerative processes [43,45]. 
 
Despite the diffuse expression of the liver type arginase I (AI) in CNS [28], arginase activity 
in the brain seems predominantly due to the mitochondrial arginase II (AII) [16,44]. It was 
proposed that AII acts in combination with arginine biosynthetic pathways in order to 
modulate arginine levels [44], and that it is involved in down-regulation of NO synthesis [15]. 
Nothing is known on the precise cellular localization of AII in CNS. 
 
For better understanding the CNS regulation of arginine transport, recycling and degradation, 
a detailed localization study of the brain expression of these genes was needed first. In this 
study, we present the precise distribution of CAT1, CAT3, AS, AL, nNOS and AII mRNAs in 
the brain of adult rat by non-radioisotopic in situ hybridization (ISH). 
 
 
 
2. Materials and Methods 
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cDNAs, plasmids and riboprobes synthesis. 
Specific cDNA fragments for rat AS (AS [41], nt 340 to 790), AL (AL [2], nt 880 to 1350), 
CAT1 (CAT1 [40], nt 202-804), CAT3 (CAT3 [17], nt 795-1839), nNOS (nNOS [9], nt 300-
2150) and arginase II (AII [20], nt 86-1211) were obtained by reverse transcription coupled to 
PCR, and cloned in the vector pGEM-3Zf(+) into the HincII site. The resulting plasmids were 
linearized as follows: pGEM-AS, pGEM-AL, pGEM-CAT1, pGEM-CAT3, pGEM-nNOS 
and pGEM-AII with HindIII to yield antisense probes for CAT1 and CAT3, and sense probes 
for AS, AL, nNOS and AII; pGEM-AS, pGEM-AL, pGEM-CAT1, pGEM-CAT3, and 
pGEM-nNOS with XbaI to yield antisense probes for AS, AL and nNOS, and sense probes 
for CAT1 and CAT3; pGEM-AII with EcoRI to yield antisense probe for AII. The linearized 
plasmids were gel-purified and used as templates for digoxigenin labelled riboprobe 
synthesis, using T7- or SP6-RNA polymerases (Promega, Madison, WI). The transcription 
mixture included 1mM ATP, GTP and CTP, 0.7mM UTP and 0.3mM digoxigenin-UTP 
(Roche Molecular Biochemicals, Basel, Switzerland). After digestion of the DNA templates 
by RQI-DNase (Promega, Madison, WI), the RNA probes were purified by two ethanol 
precipitations and resuspended in diethylpyrocarbonate (DEPC, Fluka, Buchs, Switzerland) 
treated water. 
 
In situ hybridization and immunohistochemistry 
3 male adult Sprague-Dawley rats (300 g, BRL, Basel, Switzerland) were deeply anesthetized 
(10 mg/rat Ketalar, Parke davis, USA), rapidly perfused with DEPC-treated PBS and sacrified 
by decapitation. Their brain was extracted within 2 minutes, immediately embedded in tissue 
freezing medium (Jung, Nussloch, Germany) and frozen in isopentane and dry ice. Brains 
were kept at -80°C until used, then cut and analyzed by ISH as described [6]. Briefly, 
cryosections 12 µm thick were postfixed 10 minutes in 4% paraformaldehyde-PBS, washed 
2x15 minutes in PBS containing 0.1% fresh DEPC and equilibrated 15 minutes in 5xSSC. 
Sections were then hybridized (58°C for 40 h in 5xSSC, 50% formamide and 40 µg/ml 
salmon sperm DNA) with digoxigenin-labelled antisense and sense riboprobes (400 ng/ml) 
for rat AS, AL, CAT1, CAT3, nNOS and AII. Sections were washed (30 minutes in 2xSSC at 
room temperature, 1 hour in 2xSSC at 65°C, 1 hour in 0.1xSSC at 65°C) and stained with 
alkaline-phosphatase (15 hours at room temperature) as described [6]. After staining, sections 
were dehydrated and mounted (Eukitt, O.Kindler Gmbh & Co., Freiburg, Germany). The 
  6 
specificity of hybridization was ascertained by the use of sense probes for AS, AL, CAT1, 
CAT3, nNOS and AII genes having the same length, GC content and activity of digoxigenin 
labelling as the corresponding antisense probes. In each ISH experiment, a section hybridized 
with a specific antisense probe was always preceded or followed by an adjacent section 
hybridized with the corresponding sense control probe. 
 
Immunohistochemical labelling of neurons, astrocytes and oligodendrocytes was carried out 
using monoclonal antibodies directed against Microtubule Associated Protein 2 (MAP2), 
Glial Fibrillary Acidic Protein (GFAP) (Roche Molecular Biochemicals, Basel, Switzerland) 
and Myelin Basic Protein (MBP) (Boehringer Ingelheim, Germany), respectively. MAP2, 
GFAP and MBP immunohistochemical stainings were alternated with the ISH stainings, 
generally in the following order: ISH for CAT1 (antisense and sense) / MAP2 / ISH for CAT3 
and AS (antisense and sense) / GFAP / ISH for AL and nNOS (antisense and sense) / MBP / 
ISH for AII (antisense and sense). When needed, the order of immunohistochemical stainings 
was modified to precise the cell identification of a transcript localized by ISH. 12 μm thick 
cryosections were fixed 1 hour in 4% paraformaldehyde-PBS at room temperature, then 
washed 3x5 minutes in PBS. Primary antibody (diluted 1:100 in PBS containing 1% bovine 
serum albumin and 0.3% Triton X100) was applied overnight at 4°C. Sections were rinsed 
3x5 minutes in PBS, and an anti-mouse IgG (Sigma) bridging antibody (diluted 1:100 in PBS 
containing 1% bovine serum albumin and 0.3% Triton X100) was applied for 1 hour at room 
temperature. Sections were rinsed 3x5 minutes in PBS, and the complex alkaline phosphatase 
/ anti-alkaline phosphatase (Sigma, diluted 1:100 in PBS containing 1% bovine serum 
albumin and 0.3% Triton X100) was applied for 1 hour at room temperature. Sections were 
rinsed 3x5 minutes in PBS, and stained and mounted as described above for ISH. 
 
Histological analysis 
Sections were observed and photographed on an Olympus microscope (Olympus Opticals, 
Japan). No divergence of results was observed between the three male rats analysed. Brain 
structures were identified according to Paxinos and Watson [31]. 
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3. Results 
 
A semi-quantitative description of CAT1, CAT3, AS, AL, nNOS and AII mRNA levels in the 
different brain structures in given in Table 1. The specificity of hybridization was ascertained 
by the absence of signal obtained with sense probes for CAT1, CAT3, AS, AL, nNOS and AII 
genes (Fig. 2-e,g,i,k,m,o). 
 
Cationic amino acid transporter 1 (CAT1) 
The CAT1 mRNA was found in both neurons and glial cells of the rat brain, and its cellular 
localization was perinuclear. In telencephalon, CAT1 was expressed throughout the neocortex 
(Fig. 2-b,d), in the putamen, globus pallidum, nucleus accumbens, pyriform cortex and its 
transition towards the amygdala nuclei (Fig. 2-k). It was further detected in the anterior 
olfactory nucleus and the anterior intrabulbar commissure. In hippocampus, the CAT1 
transcript was localized at high levels in the CA 1 to 3 layers, the dentate gyrus as well as the 
polymorphic and molecular layers, where it stained both neurons and astrocytes (Fig. 3-
a,c,d,e). Most structures of diencephalon, midbrain, pons and medulla showed the CAT1 
transcript with particularly high levels in the gigantocellular reticular nucleus (Fig. 4a). In 
cerebellar cortex, CAT1 was expressed in the granular and molecular layers as well as in the 
Purkinje cells (Fig. 4-c). CAT1 was also found in the deep nuclei of cerebellum. The CAT1 
mRNA was expressed at low levels in white matter structures of corpus callosum and 
cerebellum, in cells identified as oligodendrocytes by MPB staining (Fig. 2-b, 4-c and data 
not shown). CAT1 transcript was also revealed in the choroid plexus (data not shown). 
 
Cationic amino acid transporter 3 (CAT3) 
The CAT3 mRNA was detectable in neurons only, and was particularly high in ventral basal 
ganglia, ventral hypothalamus and midbrain nuclei. In every case, the CAT3 transcript 
localization was diffuse and included neuronal prolongations. In telencephalon, the CAT3 
mRNA was found at low levels in neocortex, with higher levels in layers II and III (Fig. 2-f). 
The signal was diffuse and included fibers, with some rare neurons expressing it at higher 
levels (Fig. 2-f). High expression was also observed in the entorhinal cortex and subiculum 
(data not shown). The external capsule of the putamen presented a high level of CAT3 
transcript, whereas low levels were found in its central part. High levels of CAT3 mRNA 
were found in ventral striatum and islands of Calleja (Fig. 2-l). CAT3 gene expression was 
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also found in the anterior olfactory nucleus, but not in the anterior commissure. In 
hippocampus, CAT3 transcript was localized at high levels in CA1, but less in CA3. The 
dentate gyrus presented a high level of expression, and rare neurons of the polymorphic and 
molecular layers were positive (Fig. 3-f). In diencephalon, the CAT3 mRNA was found at 
low levels in thalamic and hypothalamic nuclei (Table 1). The hypothalamic premammillary 
ventral nucleus showed scattered neurons with high levels of CAT3 transcript. In midbrain, 
CAT3 was expressed in the superior colliculus, but barely detectable in the inferior colliculus. 
Higher levels were found in red nucleus and substantia nigra. In pons and medulla, a diffuse 
and low signal was observed, with a high level of expression in vestibular and reticulate 
formation nuclei. In cerebellar cortex, CAT3 mRNA was highly expressed in the granular 
layer and the Purkinje cells, and at low levels in the molecular layer (Fig. 4-d). It was 
expressed at very low levels in the deep nuclei of cerebellum. The CAT3 mRNA was absent 
from any white matter structure (Fig. 4-d). CAT3 transcript was expressed in the choroid 
plexus (data not shown). 
 
Argininosuccinate synthetase (AS) 
In the whole rat brain, the AS mRNA was localized in neurons and not detectable in glial 
cells. In telencephalon, the AS mRNA was found in most layers of neocortex, including 
higher levels in scattered neurons as well as in the deepest cells of layer VI (Fig. 2-c,h). 
Scattered neurons with high levels of AS mRNA were localized in putamen, septum, globus 
pallidum, nucleus accumbens, islands of Calleja, pyriform cortex and amygdala. AS was also 
expressed in anterior olfactory nuclei. In hippocampus, the AS transcript was localized at low 
levels in the dentate gyrus, and barely detectable in CA, polymorphic and molecular layers 
(Fig. 3-g). Most nuclei of diencephalon expressed the AS mRNA. In midbrain, it was 
expressed at very low levels, together with scattered neurons showing higher expression. The 
AS mRNA was expressed in most structures of pons and medulla, with particularly high 
levels in the gigantocellular reticular nucleus (Fig. 4-b). In cerebellar cortex, the AS transcript 
was highly expressed in the granular and molecular layers, but was absent from the Purkinje 
cells (Fig.4-f). It could not be detected in the deep nuclei of cerebellum nor in white matter 
(Fig. 2-c and 4f). It was also absent from the choroid plexus (data not shown). 
 
 
Argininosuccinate lyase (AL) 
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The AL mRNA was found at low level of expression in most structures of the rat brain, both 
in neurons and astrocytes, but seemed absent from oligodendrocytes. In most of the brain 
cells, its localization was perinuclear. However, some brain areas presented also a cell process 
localization of the AL transcript. This was particularly the case in neocortex (diffuse signal, 
Fig. 2-j). AL mRNA was also observed in ventral striatum, islands of Calleja and nucleus 
accumbens (Fig. 2-m), as well as in the anterior olfactory nucleus. In hippocampus, the AL 
transcript was localized at low levels in the CA layer and the dentate gyrus, and barely 
detectable in the polymorphic and molecular layers (Fig. 3-h). The AL mRNA was present at 
low levels in diencephalon, midbrain, pons and medulla, with peculiar expression in 
vestibular and solitary tract nuclei. In cerebellar cortex, it was expressed at low levels in the 
granular and molecular layers, as well as the Purkinje cells (Fig. 4-e). No expression could be 
observed in the deep nuclei of cerebellum. Except for a few astrocytes in corpus callosum, the 
AL mRNA was absent from any white matter structure (Fig. 4-e). The AL transcript was 
expressed in the choroid plexus (data not shown). 
 
Neuronal Nitric Oxide Synthase (nNOS) 
In most structures of the brain, the nNOS mRNA was not detectable or expressed at very low 
levels, except in scattered neurons showing very high levels of transcript localized also in the 
cell processes (Fig. 2-l). Glial cells did not express nNOS transcript. In telencephalon, 
scattered neurons with very high levels of nNOS transcript were localized in neocortex (Fig. 
2-l), putamen, globus pallidum, nucleus accumbens and pyriform cortex. The islands of 
Calleja and the anterior olfactory nuclei were strongly positive for nNOS mRNA. In 
hippocampus, nNOS transcript was very low in the dentate gyrus and the CA layer, and high 
in scattered neurons throughout the polymorphic and molecular layers (Fig. 3-i). In 
diencephalon, it was absent from thalamus, except from the stria medullaris thalami. In 
hypothalamus, ventromedial hypothalamic and premammillary nuclei were strongly positive. 
In midbrain, the nNOS transcript was predominantly found in the superficial gray layer of the 
superior colliculus and in the dorsal cortex of the inferior colliculus. It was also found in the 
red nucleus. In pons and medulla, nNOS mRNA was localized in pontine nucleus, giant 
neurons of the solitary tract, as well as in the subpedunculate tegmentum and subcoeruleus 
nuclei. In cerebellum, it was highly expressed in the granular and molecular layers, but was 
absent from the Purkinje cells (Fig. 4-g). It was expressed at low levels in scattered neurons 
of the deep nuclei of cerebellum. nNOS transcript was absent from choroid plexus (data not 
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shown). 
 
Arginase II (AII) 
The AII mRNA was found in most structures of the rat brain, both in neurons and glial cells 
(Fig. 2-n and 2-j). Its cellular localization was perinuclear. In telencephalon, the arginase II 
gene was expressed throughout neocortex (Fig. 2-n) and corpus callosum, as well as  
putamen. High levels were observed in ventral striatum, nucleus accumbens and islands of 
Calleja (Fig. 2-n), pyriform cortex and its transition towards the amygdala nuclei. In 
hippocampus, the arginase II transcript was more expressed in CA1 than CA3 (Fig. 3-b). The 
dentate gyrus as well as neurons and astrocytes of the polymorphic and molecular layers 
expressed high levels of AII mRNA (Fig. 3-b,c,d,j). The AII transcript was localized at low 
levels in most structures of diencephalon, midbrain, pons and medulla. In cerebellar cortex, it 
was highly expressed in the granular and molecular layers, but was absent from the Purkinje 
cells (Fig. 4-h). It was also localized in numerous cell bodies of the cerebellar white matter, in 
cells identified as oligodendrocytes by MBP staining (Fig. 4-h and data not shown). The AII 
gene was expressed at low levels in the deep nuclei of cerebellum. AII transcript was also 
expressed in the choroid plexus (data not shown). 
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4. Discussion 
 
Expression of CAT1, CAT3, AS, AL, nNOS and AII 
Previous reports have described the presence of CAT1 in the rodent brain by northern blotting 
and RT-PCR experiments [18,22,25], but a precise distribution of CAT1 expression in CNS is 
lacking. We show in this study that the CAT1 mRNA is found both in neurons and astrocytes 
of the whole brain, and most probably in oligodendrocytes as well. CAT3 has been described 
in the rodent brain, and its mRNA was mostly localized in diencephalon and midbrain 
[17,18], which fits with the results we obtained in this study. In addition, we show that the 
CAT3 mRNA is predominantly expressed by neurons, and that CAT3 mRNA is also 
expressed in telencephalon, brainstem and cerebellum. The presence of AS and lyase AL 
enzyme activities and gene expression are known since a long time in CNS [4,27,28,34]. Our 
findings by ISH demonstrate the expression of AS mRNA in neurons, but not in glial cells, 
and a diffuse and low signal for AL transcript both in neurons and astrocytes. The distribution 
of AS and AL transcripts we found fits well with previous immunohistochemical studies 
[4,27,28]. We have further demonstrated the expression of AL mRNA in the Purkinje cells of 
cerebellar cortex, which validates data at the protein levels where the signal specificity 
obtained has been described as dubious [28]. Our ISH study has shown that in most part of the 
rat brain, nNOS mRNA is expressed at high levels in scattered neurons of the whole brain, in 
the cortex of cerebellum (molecular and granular layers), as well as in few nuclei of 
diencephalon, midbrain, brainstem. Isolated neurons with lower levels of expression were 
found also in diverse part of CNS. Our data are in accordance with previous reports on the 
adult rodent brain, either at the transcript or the protein level [8,19]. Data about arginase 
expression in CNS are contradictory. Whereas AI, the liver form, was described by 
immunohistochemistry and localized diffusely in CNS [28], other studies could not detect the 
AI mRNA in different brain regions [16], but could detect the non-hepatic AII transcript 
[16,44]. To our knowledge, no data about the AII localization in the brain have been 
published. Our ISH study shows that the AII mRNA is distributed uniformly in CNS and 
found in most neurons and astrocytes, except for a few cells like the Purkinje neurons of the 
cerebellar cortex which do not express AII mRNA. 
 
Localization of transcripts in the CNS cells 
All transcripts we have studied were localized or concentrated in the perinuclear region of 
brain cells. However, an interesting finding is the presence of CAT3, AL and nNOS 
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transcripts in the cell processes. This is easily detectable for nNOS, due to the isolation of the 
neurons expressing it, and more diffuse for CAT3 and AL, expressed by much more 
numerous cells, which however present a diffuse mRNA localization in dense fiber regions, 
particularly in the cortex of telencephalon. A discrimination between axons and dendrites 
(CAT3, AL) or astrocyte processes (AL) is however difficult. For nNOS, the expression of 
the mRNA in the processes appears to be dendritic. Thus, CAT3, AL and nNOS mRNAs 
might be transported along the cell processes, in order to allow the brain cells to translate 
these proteins at the site they are needed, in a similar fashion as described in dendrites for the 
MAP2 mRNA [13]. This would allow the cell to respond rapidly to immediate peripheral 
needs in these proteins. It does not exclude an anterograde transport of newly translated 
CAT1, CAT3, AS, AL, nNOS and AII proteins towards cell processes, as observed for 
example for AS in previous immunohistochemical studies [4,27]. 
 
Patterns of cellular expression, arginine uptake and metabolism in brain cells 
The presence of y+ carrier system has been shown at the blood brain barrier [40], in cultured 
neurons [46], in synaptosomes [1] and in primary astrocyte cultures [35]. The expression of 
CAT1 at the blood brain barrier and choroid plexus [40] as well as our findings showing its 
expression in the whole brain (Table 2) renders CAT1 the prime candidate for basic arginine 
trafficking between brain cells. CAT3 on the other hand seems restricted to neurons, and 
could more specifically be responsible for arginine uptake and exchange by neurons. In CNS, 
free L-arginine seems predominantly localized in glial cells [3], which can release arginine 
upon excitatory amino acid receptor activation [12]. This suggests that arginine trafficking 
between blood and astrocytes, between astrocytes and neurons, as well as between neurons 
themselves, is important not only for protein synthesis, but also in the cellular response to 
stimulation. Another form of CAT, CAT2(B), could be responsible of arginine trafficking in 
glial cells; it was localized in brain by northern blotting [18,25] and found up-regulated in 
primary astrocytes upon LPS and IFNγ treatment [39]. Further work should localize precisely 
the CAT2(B) expression in the brain. 
 
As shown in Table 1, patterns of expression of the genes we studied differ, depending on cell 
types and localization. However, even within the same anatomical region and morphological 
cell types, differences of expression were found. The data are summarized in Table 2. 
Coexpression of all genes of the citrulline-NO cycle is a prerequisite for assuming that cells 
do not depend for their NO production on intercellular arginine transport. Such a pattern can 
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only be found in scattered neurons mainly localized in telencephalon, midbrain and 
brainstem, in a few nuclei of hypothalamus and brainstem, as well as in the cerebellar cortex. 
Neurons expressing AS and AL but not nNOS might be involved in the recycling of the 
citrulline produced by NO synthesizing cells into arginine. This raises the question of 
citrulline trafficking between brain cells and uptake of arginine by NOS expressing cells. The 
expression of eNOS and iNOS in CNS as well as the induction of iNOS in pathological 
circumstances suggest that the citrulline-NO cycle might be essential also in cells not 
expressing nNOS. Neurons and glial cells expressing AL but lacking AS mRNAs raise the 
question of argininosuccinate release, trafficking and potential role as messenger or 
neurotransmitter in or between brain cells, as already suggested by similar observations [29]. 
Alternatively, the dormant AS gene could be induced in these cells under specific 
pathological conditions, as it is up-regulated in primary astrocytes upon LPS and IFNγ 
treatment [36] and, together with the AL gene, in astrocytes of reaggregated brain cell 
cultures exposed to ammonium chloride [7]. 
 
Our findings indicate that most cells of the brain appear able to regulate their arginine levels 
by AII. Purkinje neurons are an exception to this. AII is proposed to act in combination with 
arginine biosynthetic pathways in order to modulate arginine levels [44], to decrease NO 
synthesis or to block NOS dependent apoptosis, as suggested by recent works on macrophage 
cell lines [15]. However, the absence of NOS expression in most brain cells points to the fact 
that arginine is used for more general purposes, such as protein and creatine synthesis. In 
CNS, astrocytes are the main cells synthesizing polyamines [24], which have ornithine as 
substrate. Astrocytes have been shown as the predominant locus of expression of UT3, a urea 
transporter thought to participate in the elimination of urea by the brain [5]. These findings 
could be put in relation with the astrocytic expression of AII, which metabolizes arginine to 
ornithine and urea. 
 
Our data suggest that all intermediates of the citrulline-NO cycle might be exchanged 
between brain cells in order to ensure their needs in NO and arginine. The precise description 
of the restricted expression of CAT 1 and 3, AS, AL, nNOS and AII by specific cells is a 
prerequisite for understanding the citrulline-NO cycle and the roles of arginine in the brain, 
which will have to take into account interactions between cells in close vicinity. 
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Figure legends: 
 
Figure 1: Citrulline-NO cycle, arginine uptake and metabolism. A I+II: arginase I and II, 
AL: argininosuccinate lyase, Arg: arginine, AS: argininosuccinate synthetase, ASA: 
argininosuccinic acid, Asp: aspartate, CAT: cationic amino acid transporter, Cit: citrulline, 
Fum: fumarate, NO: nitric oxide, NOS: nitric oxide synthase, Orn: ornithine. 
 
Figure 2: Expression of CAT1, CAT3, AS, AL, nNOS and AII in the telencephalic 
cortex. a-c: Low magnification of a sagittal section of rat telencephalic cortex. d-o: 
enlargement of layers II/III of cortex, as localized by rectangle pictured in 2-b. Neuronal 
immunostaining for MAP2 (a), ISH antisense staining for CAT1 (b,d), CAT3 (f), AS (c,h), 
AL (j), nNOS (l) and AII (n), ISH sense staining for CAT1 (e), CAT3 (g), AS (i), AL (k), 
nNOS (m) and AII (o). In2-c, the deepest cells of layer VI are indicated by an arrowhead. In 
panels 2-d to 2-n, neurons are indicated by arrowheads and astrocytes by arrows. 2-h and 2-l 
are adjacent sections stained for AS (h) and nNOS (l), showing two neurons with colocalized 
AS and nNOS mRNAs. Bar: 100 µm. 
 
Figure 3: Expression of CAT1, CAT3, AS, AL, nNOS and AII in the hippocampus and 
basal ganglia. a-b: Low magnification of a sagittal section of rat hippocampus. c-j: 
Enlargement of dentate gyrus and hilus, localized by the rectangle outlined in 2-a. k-n: 
Enlargement of basal ganglia including nucleus accumbens and island of Calleja. ISH 
antisense staining for CAT1 (a,e,k), CAT3 (f,l), AS (g), AL (h,m), nNOS (i) and AII (b,j,n). 
Neuronal immunostaining for MAP2 (c) and astrocytic immunostaining for GFAP (d). From 
3-c to 3-l, neurons are indicated by arrowheads and astrocytes by arrows. ca1-3: Ammon's 
horn 1-3, dg: dentate gyrus, ic: island of Calleja, na: nucleus accumbens. Bar: 100 µm. 
 
Figure 4: Expression of CAT1, CAT3, AS, AL, nNOS and AII in medulla and 
cerebellum. a,b: High magnification of a sagittal section in rat gigantocellular nucleus of the 
reticular formation. c-h: high magnification of cerebellar cortex. ISH antisense staining for 
CAT1 (a,c), CAT3 (d), AS (b,f), AL (e), nNOS (g) and AII (h). From 4-b to 4-h, Purkinje 
cells are indicated by arrowheads and astrocytes/oligodendrocytes of white matter by arrows. 
gr: granular layer, mol: molecular layer, wm: white matter. Bar: 100 µm. 
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Table 2: Summary of CAT1, CAT3, AS, AL, nNOS and AII expression in the rat brain. 
 
  CAT1 CAT3 AS AL nNOS AII 
        
Neurons telencephalon, diencephalon, brainstem + + + +  + 
 scattered neurons (telencephalon, midbrain, brainstem), 
cerebellar cortex (molecular and granular layers) 
+ + + + + + 
 midbrain, brainstem + +  +  + 
 Purkinje cells + +  +   
        
Astrocytes grey matter +   +  + 
 white matter +     + 
        
Oligodendrocytes  +     + 
 
Main structures for specific patterns of expression are indicated. 
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